FDA

It is Game On! at Commissioner Scott Gottlieb's U.S. Food and Drug Administration.
Bacteria that are resistant to one, multiple or even all known antibiotics, commonly known as superbugs, are one of the leading concerns in the medical and scientific communities. 
For some time, we have been covering the investigation into the practices used to produce the homeopathic teething products that allegedly caused illnesses and deaths of infants.
The cancer drug business is quite a profitable one. A “high risk, high reward” proposition has been the narrative for those in research and development (R&D). Successes, marketing, patent protection and discovery cost money.
When it comes to cancer breakthroughs, there have not been many announcements as big as the one made this week by the U.S.
Homeopathic products look just like the medicines they are placed next to on the shelves. However, when it comes to how these products are made - they are vastly different.
Who among us hasn’t chuckled at a television prescription drug ad when it ventures into a litany of wide-ranging potential side effects like anal leakage to erections lasting more than four hours?
Just because you did something once last year in Mexico does not mean you can do it here. That is the message the US Food and Drug Administration (FDA) is sending to a physician in New York.
The FDA has been busy lately, from protecting children from fake autism treatments to putting enough pressure on the makers of